These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7570747)

  • 1. AMPA antagonist LY293558 does not affect the severity of hypoxic-ischemic injury in newborn pigs.
    LeBlanc MH; Li XQ; Huang M; Patel DM; Smith EE
    Stroke; 1995 Oct; 26(10):1908-14; discussion 1914-5. PubMed ID: 7570747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmethyl tirilazad improves neurologic function after hypoxic ischemic brain injury in piglets.
    Feng Y; LeBlanc MH; LeBlanc EB; Parker CC; Fratkin JD; Qian XB; Patel DM; Huang M; Smith EE; Vig PJ
    Crit Care Med; 2000 May; 28(5):1431-8. PubMed ID: 10834691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schedule-controlled behavioral effects of the selective 2-amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic acid antagonist LY293558 in pigeons.
    Benvenga MJ; Ornstein PL; Leander JD
    J Pharmacol Exp Ther; 1995 Oct; 275(1):164-70. PubMed ID: 7562545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MK-801 does not protect against hypoxic-ischemic brain injury in piglets.
    LeBlanc MH; Vig V; Smith B; Parker CC; Evans OB; Smith EE
    Stroke; 1991 Oct; 22(10):1270-5. PubMed ID: 1926238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampus.
    Bond A; Lodge D; Hicks CA; Ward MA; O'Neill MJ
    Eur J Pharmacol; 1999 Sep; 380(2-3):91-9. PubMed ID: 10513567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AMPA antagonist LY293558 improves functional neurological outcome following reversible spinal cord ischemia in rabbits.
    Bowes MP; Swanson S; Zivin JA
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):967-72. PubMed ID: 8784241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intrathecal non-NMDA EAA receptor antagonist LY293558 in rats: a new class of drugs for spinal anesthesia.
    Von Bergen NH; Subieta A; Brennan TJ
    Anesthesiology; 2002 Jul; 97(1):177-82. PubMed ID: 12131120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal.
    Rasmussen K; Kendrick WT; Kogan JH; Aghajanian GK
    Neuropsychopharmacology; 1996 Nov; 15(5):497-505. PubMed ID: 8914123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the AMPA/kainate receptor antagonist LY293558 in a rat model of postoperative pain.
    Lee HJ; Pogatzki-Zahn EM; Brennan TJ
    J Pain; 2006 Oct; 7(10):768-77. PubMed ID: 17018337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the GluK1/AMPA receptor antagonist LY293558 against seizures and neuropathology in a soman-exposure model without pretreatment and its pharmacokinetics after intramuscular administration.
    Apland JP; Aroniadou-Anderjaska V; Figueiredo TH; Green CE; Swezey R; Yang C; Qashu F; Braga MF
    J Pharmacol Exp Ther; 2013 Jan; 344(1):133-40. PubMed ID: 23042954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo studies in rats with LY293558 suggest AMPA/kainate receptor blockade as a novel potential mechanism for the therapeutic treatment of anxiety disorders.
    Alt A; Weiss B; Ogden AM; Li X; Gleason SD; Calligaro DO; Bleakman D; Witkin JM
    Psychopharmacology (Berl); 2006 Apr; 185(2):240-7. PubMed ID: 16470401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose given after hypoxic ischemia does not affect brain injury in piglets.
    LeBlanc MH; Huang M; Patel D; Smith EE; Devidas M
    Stroke; 1994 Jul; 25(7):1443-7; discussion 1448. PubMed ID: 8023361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic neuroprotective effects by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitors in global cerebral ischaemia.
    Hicks CA; Ward MA; Swettenham JB; O'Neill MJ
    Eur J Pharmacol; 1999 Sep; 381(2-3):113-9. PubMed ID: 10554878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans.
    Sang CN; Hostetter MP; Gracely RH; Chappell AS; Schoepp DD; Lee G; Whitcup S; Caruso R; Max MB
    Anesthesiology; 1998 Nov; 89(5):1060-7. PubMed ID: 9821993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo antagonism of AMPA receptor activation by (3S, 4aR, 6R, 8aR)-6-[2-(1(2)H-tetrazole-5-yl) ethyl] decahydroisoquinoline-3-carboxylic acid.
    Schoepp DD; Lodge D; Bleakman D; Leander JD; Tizzano JP; Wright RA; Palmer AJ; Salhoff CR; Ornstein PL
    Neuropharmacology; 1995 Sep; 34(9):1159-68. PubMed ID: 8532186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraine.
    Sang CN; Ramadan NM; Wallihan RG; Chappell AS; Freitag FG; Smith TR; Silberstein SD; Johnson KW; Phebus LA; Bleakman D; Ornstein PL; Arnold B; Tepper SJ; Vandenhende F
    Cephalalgia; 2004 Jul; 24(7):596-602. PubMed ID: 15196302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective protection against AMPA- and kainate-evoked neurotoxicity by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisoquinoline- 3-carboxylic acid (LY293558) and its racemate (LY215490).
    Schoepp DD; Salhoff CR; Fuson KS; Sacaan AI; Tizzano JP; Ornstein PL; May PC
    J Neural Transm (Vienna); 1996; 103(8-9):905-16. PubMed ID: 9013384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids.
    Kest B; McLemore G; Kao B; Inturrisi CE
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1249-55. PubMed ID: 9400000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoflurane and pentobarbital reduce AMPA toxicity in vivo in the rat cerebral cortex.
    Kimbro JR; Kelly PJ; Drummond JC; Cole DJ; Patel PM
    Anesthesiology; 2000 Mar; 92(3):806-12. PubMed ID: 10719959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of the AMPA receptor antagonist LY-293558 in focal cerebral ischemia in the cat.
    Bullock R; Graham DI; Swanson S; McCulloch J
    J Cereb Blood Flow Metab; 1994 May; 14(3):466-71. PubMed ID: 8163588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.